# Estrogen Administration for the Treatment of NASH in Postmenopausal Women

> **NCT04833140** · PHASE3 · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- NASH - Nonalcoholic Steatohepatitis

## Interventions

- **DRUG:** Estradiol patch
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04833140
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-02
- **Primary completion:** 2027-05-31
- **Final completion:** 2027-05-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04833140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04833140, "Estrogen Administration for the Treatment of NASH in Postmenopausal Women". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04833140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*